| Literature DB >> 24624138 |
Mrinal Pahwa1, Archna R Pahwa2, Mohit Girotra3, Rtika Ryfka Abrahm3, Sachin Kathuria1, Ajay Sharma1.
Abstract
Introduction. Congenital pelviureteric junction obstruction (PUJO) is one of the most common causes of hydronephrosis. Historically, open dismembered pyeloplasty has been considered the gold standard intervention for correcting PUJO. The aim of this study was to compare the surgical and functional outcomes of three different approaches, namely, open, conventional laparoscopy, and robotic pyeloplasty. Material and Methods. 60 patients underwent minimally invasive pyeloplasty (30 conventional laparoscopies and 30 robotics) for congenital PUJO at a tertiary health center in India. Demographic, perioperative, and postoperative data were prospectively collected and analyzed. The data of these patients were retrospectively compared with another cohort of 30 patients who had undergone open pyeloplasty. Results. There was significant difference in operative time, time to drain removal, hospital stay, pain score, and complications rate between open and minimally invasive pyeloplasty (P < 0.05). SFI was considerably lesser in robotic as compared to conventional laparoscopy. The success rate in OP, CLP, and RP was 93.33, 96.67, and 96.67%. Conclusion. Robotic pyeloplasty is safe, effective, and feasible. It is associated with significantly lesser operative time, lesser blood loss, less pain, shorter hospital stay, and fewer complications. It is also associated with considerably lesser surgeon fatigue as compared to conventional laparoscopy pyeloplasty.Entities:
Year: 2014 PMID: 24624138 PMCID: PMC3929287 DOI: 10.1155/2014/850156
Source DB: PubMed Journal: Adv Urol ISSN: 1687-6369
Clinical profile of patients in three groups.
| OP | CLP | RP | |
|---|---|---|---|
| Number of patients | 30 | 30 | 30 |
| Mean age (years) | 31.4 (21–45) | 34.4 (23–39) | 32 (19–49) |
| Gender (M/F) | 14/16 | 13/17 | 12/18 |
| BMI | 24.7 (19–29) | 25.5 (20–30) | 26.4 (19–30) |
| Laterality (R/L) | 13/17 | 15/15 | 14/16 |
Perioperative and postoperative outcomes in the three groups and the significance indifference between minimally invasive group and OP group. P < 0.05 was considered significant.
| OP | CLP | RP | Significance | |
|---|---|---|---|---|
| Operative time (mins) | 127.5 (112–168) | 191.56 (145–276) | 141.73 (110–235) |
|
| Mean blood loss (mL) | 114.47 (65–198) | 55.24 (35–120) | 46.37 (30–95) |
|
| Crossing vessel (%) | 26.67 | 33.3 | 33.3 | NS |
| Surgeon fatigue index | Not calculated | 6.8 | 3.9 |
|
| Pain score | 7.9 | 4.77 | 4.16 |
|
| Time to drain removal (days) | 3.58 (2–12) | 2.68 (1–8) | 2.03 (1–6) |
|
| Mean hospital stay (days) | 4.83 (3–8) | 3 (2–6) | 2.45 (2–6) |
|
| Complications (%) | 16.1 | 11.4 | 8 | NS, |
| Followup (months) | 35 (24–60) | 18 (8–23) | 13.5 (5–20) | |
| Recurrence | 2/30 | 1/30 | 1/30 | NS, |
NS: not significant.
Summary of case series on robotic pyeloplasty.
| Author | Year | Type of study | Number | Mean age (years) | Mean operative time (minutes) | Blood loss (mL) | Complications (%) | Hospital stay (days) | Success (%) |
|---|---|---|---|---|---|---|---|---|---|
| Gettman et al. [ | 2002 | CC | 9 | NA | 138.8 | 50 | 11.1 | 4.7 | 100 |
| Peschel et al. [ | 2004 | R | 49 | NA | 124 | 50 | 0 | 5.5 | 100 |
| Siddiq et al. [ | 2005 | R | 26 | 34.5 | 245 | 69 | 11.5 | 2 | 100 |
| Mendez-Torres et al. [ | 2005 | R | 32 | 31.2 | 300 | 52 | 11.5 | 2 | 100 |
| Palese et al. [ | 2005 | R | 38 | 39.3 | 225.6 | 77.3 | 10.5 | 2.9 | 94.7 |
| Bernie et al.* [ | 2005 | CR | 7/7 | 32 | 324 | 60 | 28.5 | 2.5 | 100 |
| Patel [ | 2005 | R | 50 | 31 | 122 | 40 | 0 | 1.1 | 100 |
| Weise and Winfield* [ | 2006 | CR | 31/14 | 26 | 271 | 100 | 6 | 2.1 | 97 |
| Link et al.* [ | 2006 | CR | 10/10 | 46.5 | 173.8 | NA | 10 | NA | 100 |
| Atug et al. [ | 2006 | R | 44 | 32.8 | 219.4 | 50 | 0 | 1.1 | 100 |
| Schwentner et al. [ | 2007 | R | 92 | 35.1 | 108 | <50 | 3.3 | 4.57 | 96.7 |
| Yanke et al. [ | 2008 | R | 29 | 41.2 | 196 | 39 | 13.7 | 2.2 | 100 |
| Erdeljan et al. [ | 2008 | R | 55 | na | 171 | 57 | 1.8 | 2.3 | 95 |
| Gupta et al. [ | 2010 | R | 85 | 24.8 | 121 | 45 | 9.4 | 2.5 | 96.5 |
| Mufarrij et al. [ | 2008 | R | 140 | 38.5 | 217 | 59.4 | 9.2 | 2.1 | 95.7 |
| Erdeljan et al. [ | 2010 | R | 90 | na | 167.7 | 53.4 | 5.5 | 2.53 | 93 |
| Bird et al.* [ | 2011 | CR | 98/74 | 39.6 | 189 | >50 | 5 | 2 | 100 |
R: retrospect; CC: case controlled; CR: comparative retrospect.
*comparative series comparing RP and CLP.